Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1262 press releases before 2023
-
AZD8233 reduced low-density lipoprotein cholesterol levels by 73% in patients with high-risk hypercholesterolemia in ETESIAN Phase IIb trial
-
Ondexxya approved in Japan for reversal of acute major bleeds in patients on Factor Xa inhibitors
-
AstraZeneca aims to transform the oncology treatment landscape with diverse early pipeline and novel combinations at AACR
-
Evusheld long-acting antibody combination approved in the EU for pre-exposure prophylaxis (prevention) of COVID-19 in a broad population
-
Evusheld long-acting antibody combination recommended for approval in the EU for the pre-exposure prophylaxis (prevention) of COVID-19
-
Update on CALLA Phase III trial of concurrent use of Imfinzi and chemoradiotherapy in locally advanced cervical cancer
-
AstraZeneca launches global R&D Postdoctoral Challenge to accelerate scientific discovery and diversity
-
AstraZeneca reaches settlement agreement resolving patent litigation related to Ultomiris
-
AstraZeneca’s antibody combination, Evusheld▼ (tixagevimab co-packaged with cilgavimab) authorised for use in Great Britain for pre-exposure prophylaxis (prevention) of COVID-19
-
Lynparza reduced risk of death by 32% in the adjuvant treatment of patients with germline BRCA-mutated high-risk early breast cancer
Latest articles and press releases
All of our latest press releases and articles are available to explore
Use a maximum of two downloads here
